Drug profile · INN
ganciclovir
VITRASERT IMPLANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ganciclovir (VITRASERT IMPLANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN ganciclovir
Brand VITRASERT IMPLANT
Route OPHTHALMIC
Formulation CAPSULE
ATC code J05AB06
Frequently asked questions
What is ganciclovir?
ganciclovir (VITRASERT IMPLANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for ganciclovir?
VITRASERT IMPLANT is a marketed brand name for ganciclovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ganciclovir?
ganciclovir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.